SPHS Stock: Sophiris Bio, Inc. Stock Price, Analysis & Insights
Get live SPHS stock price $0.00, comprehensive Sophiris Bio, Inc. stock analysis, charts, news, and expert forecast. Real-time SPHS stock data and investment insights.
Loading chart data...
Sophiris Bio, Inc. (SPHS) Overview
Sophiris Bio, Inc. (SPHS) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, SPHS trades at $0.00 . Over the past 52 weeks, SPHS has traded between $0.00 and $0.03 , with the current price positioned at approximately 0% of this range . The stock currently trades at a price-to-earnings (P/E) ratio of 0.00 , w...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Current price: $0.00
- 52-week range: $0.00 - $0.03
- P/E ratio: 0.00
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sophiris Bio, Inc. is a biopharmaceutical entity currently in the clinical trial phase, dedicated to pioneering treatments for conditions affecting the urinary system. Its flagship investigational compound, PRX302 (topsalysin), is presently undergoin...
Company Information
- CEO
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 6
Contact Information
- Website
- https://www.sophirisbio.com
- Address
- 1258 Prospect Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 0.0)
✓ Lower volatility stock (Beta: -33.39) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sophiris Bio, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sophiris Bio, Inc.
- ⚠Investors should consider how Sophiris Bio, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
P/E Ratio (TTM)
0.00
Beta
-33.39
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SPHS with peer companies:
- Price
- $0.00
- Market cap
- 26
- Price
- $0.00
- Market cap
- 1.77K
- Price
- $0.00
- Market cap
- 44
- Price
- $0.00
- Market cap
- 117
- Price
- $0.00
- Market cap
- 34
- Price
- $0.00
- Market cap
- 17
- Price
- $0.00
- Market cap
- 25
- Price
- $0.00
- Market cap
- 12
- Price
- $0.00
- Market cap
- 3
- Price
- $0.00
- Market cap
- 1
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.